GHR: Growth hormone receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Receptor for pituitary gland growth hormone (GH1) involved in regulating postnatal body growth.
- Drugs that act on it: 6
- With a US drug page: 5
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Lonapegsomatropin | Approved | Growth hormone receptor agonist | Agonist | — |
| Pegvisomant | Approved | Growth hormone receptor antagonist | Antagonist | — |
| Somapacitan | Approved | Growth hormone receptor agonist | Agonist | — |
| Somatrogon | Approved | Growth hormone receptor agonist | Agonist | — |
| Somatropin | Approved | Growth hormone receptor agonist | Agonist | — |
| Somatrem | — | Growth hormone receptor agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Laron syndrome
- 0.83
- Short stature due to partial GHR deficiency
- 0.76
- Turner syndrome
- 0.60
- Acromegaly
- 0.60
- Pituitary dwarfism
- 0.60
- Growth delay
- 0.59
- Gonadal dysgenesis
- 0.53
- Growth hormone insensitivity syndrome
- 0.52
- Abnormality of the skeletal system
- 0.51
- HIV infectious disease
- 0.51
Drugs and mechanisms are from ChEMBL CHEMBL1976 (CC BY-SA 3.0). Gene name, function (UniProt P10912, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets